247 related articles for article (PubMed ID: 23954509)
1. Poly-L-asparagine nanocapsules as anticancer drug delivery vehicles.
Rivera-Rodríguez GR; Alonso MJ; Torres D
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):481-7. PubMed ID: 23954509
[TBL] [Abstract][Full Text] [Related]
2. In vivo evaluation of poly-l-asparagine nanocapsules as carriers for anti-cancer drug delivery.
Rivera-Rodriguez GR; Lollo G; Montier T; Benoit JP; Passirani C; Alonso MJ; Torres D
Int J Pharm; 2013 Dec; 458(1):83-9. PubMed ID: 24140546
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronan nanocapsules as a new vehicle for intracellular drug delivery.
Oyarzun-Ampuero FA; Rivera-Rodríguez GR; Alonso MJ; Torres D
Eur J Pharm Sci; 2013 Jul; 49(4):483-90. PubMed ID: 23684914
[TBL] [Abstract][Full Text] [Related]
4. PEGylated polypeptide lipid nanocapsules to enhance the anticancer efficacy of erlotinib in non-small cell lung cancer.
Kim J; Ramasamy T; Choi JY; Kim ST; Youn YS; Choi HG; Yong CS; Kim JO
Colloids Surf B Biointerfaces; 2017 Feb; 150():393-401. PubMed ID: 27825759
[TBL] [Abstract][Full Text] [Related]
5. Development of docetaxel nanocapsules for improving in vitro cytotoxicity and cellular uptake in MCF-7 cells.
Singh SK; Banala VT; Gupta GK; Verma A; Shukla R; Pawar VK; Tripathi P; Mishra PR
Drug Dev Ind Pharm; 2015; 41(11):1759-68. PubMed ID: 25686725
[TBL] [Abstract][Full Text] [Related]
6. Intracellular delivery of docetaxel using freeze-dried polysaccharide nanocapsules.
Lozano MV; Esteban H; Brea J; Loza MI; Torres D; Alonso MJ
J Microencapsul; 2013; 30(2):181-8. PubMed ID: 23088320
[TBL] [Abstract][Full Text] [Related]
7. Enhanced in vivo therapeutic efficacy of plitidepsin-loaded nanocapsules decorated with a new poly-aminoacid-PEG derivative.
Lollo G; Hervella P; Calvo P; Avilés P; Guillén MJ; Garcia-Fuentes M; Alonso MJ; Torres D
Int J Pharm; 2015 Apr; 483(1-2):212-9. PubMed ID: 25681727
[TBL] [Abstract][Full Text] [Related]
8. Self-assembled hyaluronan nanocapsules for the intracellular delivery of anticancer drugs.
Cadete A; Olivera A; Besev M; Dhal PK; Gonçalves L; Almeida AJ; Bastiat G; Benoit JP; de la Fuente M; Garcia-Fuentes M; Alonso MJ; Torres D
Sci Rep; 2019 Aug; 9(1):11565. PubMed ID: 31399627
[TBL] [Abstract][Full Text] [Related]
9. Polyglutamic acid-PEG nanocapsules as long circulating carriers for the delivery of docetaxel.
Lollo G; Rivera-Rodriguez GR; Bejaud J; Montier T; Passirani C; Benoit JP; García-Fuentes M; Alonso MJ; Torres D
Eur J Pharm Biopharm; 2014 May; 87(1):47-54. PubMed ID: 24530693
[TBL] [Abstract][Full Text] [Related]
10. Polyaminoacid nanocapsules for drug delivery to the lymphatic system: Effect of the particle size.
Abellan-Pose R; Teijeiro-Valiño C; Santander-Ortega MJ; Borrajo E; Vidal A; Garcia-Fuentes M; Csaba N; Alonso MJ
Int J Pharm; 2016 Jul; 509(1-2):107-117. PubMed ID: 27210735
[TBL] [Abstract][Full Text] [Related]
11. Enhanced in vivo antitumor efficacy of dual-functional peptide-modified docetaxel nanoparticles through tumor targeting and Hsp90 inhibition.
Jiang Y; Yang N; Zhang H; Sun B; Hou C; Ji C; Zheng J; Liu Y; Zuo P
J Control Release; 2016 Jan; 221():26-36. PubMed ID: 26643616
[TBL] [Abstract][Full Text] [Related]
12. Highly efficient system to deliver taxanes into tumor cells: docetaxel-loaded chitosan oligomer colloidal carriers.
Lozano MV; Torrecilla D; Torres D; Vidal A; Domínguez F; Alonso MJ
Biomacromolecules; 2008 Aug; 9(8):2186-93. PubMed ID: 18637687
[TBL] [Abstract][Full Text] [Related]
13. Lipid nanocapsules: a new platform for nanomedicine.
Huynh NT; Passirani C; Saulnier P; Benoit JP
Int J Pharm; 2009 Sep; 379(2):201-9. PubMed ID: 19409468
[TBL] [Abstract][Full Text] [Related]
14. Targeted nanomedicine for prostate cancer therapy: docetaxel and curcumin co-encapsulated lipid-polymer hybrid nanoparticles for the enhanced anti-tumor activity in vitro and in vivo.
Yan J; Wang Y; Zhang X; Liu S; Tian C; Wang H
Drug Deliv; 2016 Jun; 23(5):1757-62. PubMed ID: 26203689
[TBL] [Abstract][Full Text] [Related]
15. Encapsulation in lipid-core nanocapsules overcomes lung cancer cell resistance to tretinoin.
Schultze E; Ourique A; Yurgel VC; Begnini KR; Thurow H; de Leon PM; Campos VF; Dellagostin OA; Guterres SR; Pohlmann AR; Seixas FK; Beck RC; Collares T
Eur J Pharm Biopharm; 2014 May; 87(1):55-63. PubMed ID: 24525073
[TBL] [Abstract][Full Text] [Related]
16. Anticancer properties of lipid and poly(ε-caprolactone) nanocapsules loaded with ferrocenyl-tamoxifen derivatives.
Najlaoui F; Pigeon P; Aroui S; Pezet M; Sancey L; Marrakchi N; Rhouma A; Jaouen G; De Waard M; Busser B; Gibaud S
J Pharm Pharmacol; 2018 Nov; 70(11):1474-1484. PubMed ID: 30141195
[TBL] [Abstract][Full Text] [Related]
17. A Quality by design (QbD) approach on starch-based nanocapsules: A promising platform for topical drug delivery.
Marto J; Gouveia LF; Gonçalves LM; Gaspar DP; Pinto P; Carvalho FA; Oliveira E; Ribeiro HM; Almeida AJ
Colloids Surf B Biointerfaces; 2016 Jul; 143():177-185. PubMed ID: 27003468
[TBL] [Abstract][Full Text] [Related]
18. Lipid nanocapsules for intracellular drug delivery of anticancer drugs.
Lacoeuille F; Garcion E; Benoit JP; Lamprecht A
J Nanosci Nanotechnol; 2007 Dec; 7(12):4612-7. PubMed ID: 18283853
[TBL] [Abstract][Full Text] [Related]
19. Preparation and evaluation of lipid emulsified docetaxel-loaded nanoparticles.
Zhang F; Chang M; Yu Y; Zhang Y; Liu G; Wei T; Zuo T; Guan Y; Lin G; Zhao Z
J Pharm Pharmacol; 2015 Nov; 67(11):1546-55. PubMed ID: 26256262
[TBL] [Abstract][Full Text] [Related]
20. Docetaxel-loaded polyglutamic acid-PEG nanocapsules for the treatment of metastatic cancer.
Borrajo E; Abellan-Pose R; Soto A; Garcia-Fuentes M; Csaba N; Alonso MJ; Vidal A
J Control Release; 2016 Sep; 238():263-271. PubMed ID: 27476608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
